Physician profile
Susan Fox
NPI 1497712327
$3,288.58
in general payments reported to CMS, 2019-2025
27 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $382 · 2021: $526 · 2022: $727 · 2023: $133 · 2024: $94.34 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $921.86 | 2019-2023 | |
| Exeltis, USA INC. | $733.00 | 2019-2024 | Slynd |
| Pfizer INC. | $235.81 | 2019-2022 | |
| Smith+Nephew, INC. | $204.18 | 2019 | |
| Hologic Sales and Service, LLC | $162.96 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $145.50 | 2019-2022 | |
| Myovant Sciences INC. | $131.88 | 2021-2022 | |
| Therapeuticsmd, INC. | $120.21 | 2019-2021 | |
| Astellas Pharma US INC | $118.46 | 2022-2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $58.08 | 2019-2025 | |
| Organon LLC | $56.80 | 2021-2023 | Nexplanon |
| Becton, Dickinson and Company | $47.50 | 2022-2024 | Bd Onclarity |
| Millicent US INC | $45.54 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $44.87 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $32.08 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $31.33 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.51 | 2019 | |
| Ascend Therapeutics US, LLC | $24.64 | 2020 | |
| Agile Therapeutics, INC. | $24.24 | 2022 | |
| Coloplast Corp | $18.83 | 2020 | |
| Aspira Women'S Health INC | $17.41 | 2020 | |
| Exact Sciences Corporation | $16.51 | 2023 | Cologuard Collection Kit |
| Scynexis, INC. | $15.78 | 2022 | |
| Dysis Medical, INC. | $14.40 | 2019 | |
| Mission Pharmacal Company | $14.03 | 2021 | |
| Shield Therapeutics INC | $12.32 | 2022 | |
| Boston Scientific Corporation | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.